Skip to main content

Advertisement

Log in

Transforming growth factor-β1 in children with diabetic nephropathy

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Background

Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine that has numerous biological processes. Earlier research indicates that protein and mRNA production of TGF-β1 are enhanced in the renal tissues of patients with diabetic nephropathy (DN). Our aim was to evaluate the role of TGF-β1 in early prediction of DN in children with type 1 diabetes mellitus (T1DM).

Methods

Fifty patients with T1DM were enrolled in an observational study. Patients were eligible to participate if at least 3 years had passed since T1DM diagnosis. Patients were classified into two groups (A and B) according to the presence or absence of microalbuminuria, respectively. Serum TGF-β1 was measured by ELISA in the patients.

Results

Out of the 50 studied patients with T1DM, there were 23 (46%) patients with microalbuminuria. There was a significant difference between patients in group A and B as regards TGF-β1 (p < 0.001). HbA1c had very little influence in controlling for the relationship between TGF-β1 and disease duration. Diagnostic cutoff value of TGF-β1 was 358.5 pg/ml with sensitivity and specificity of 100%.

Conclusion

TGF-β1 was significantly higher in children with DN in comparison with children without. It could be used as an early indicator of DN in children with T1DM with high sensitivity and specificity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chang AS, Hathaway CK, Smithies O, Kakoki M (2016) Transforming growth factor-beta1 and diabetic nephropathy. Am J Physiol Renal Physiol 310:F689–F696

    Article  CAS  Google Scholar 

  2. Herder C, Brunner EJ, Rathmann W, Strassburger K, Tabak AG, Schloot NC, Witte DR (2009) Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 32:421–423

    Article  Google Scholar 

  3. Fukuda N, Tahira Y, Matsuda H, Matsumoto K (2009) Transforming growth factor-beta as a treatment target in renal diseases. J Nephrol 22:708–715

    CAS  PubMed  Google Scholar 

  4. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H (1999) Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10:2569–2576

    CAS  PubMed  Google Scholar 

  5. Goldberg RB (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 94:3171–3182

    Article  CAS  Google Scholar 

  6. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K (2000) Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A 97:8015–8020

    Article  CAS  Google Scholar 

  7. Ziyadeh FN (2004) Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 15(Suppl 1):S55–S57

    Article  CAS  Google Scholar 

  8. Qiao YC, Chen YL, Pan YH, Ling W, Tian F, Zhang XX, Zhao HL (2017) Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 96:e6583

    Article  CAS  Google Scholar 

  9. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN (1992) Elevated glucose stimulates TGF-beta gene expression and bioactivity in proximal tubule. Kidney Int 41:107–114

    Article  CAS  Google Scholar 

  10. Ziyadeh FN, Sharma K, Ericksen M, Wolf G (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta. J Clin Invest 93:536–542

    Article  CAS  Google Scholar 

  11. Wolf G, Ziyadeh FN (2009) Transforming growth factor-b and diabetic nephropathy. J organ dysfunct 5:130–139

    Article  Google Scholar 

  12. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kurnik BR, Kurnik PB, Weisberg LS (1997) Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46:854–859

    Article  CAS  Google Scholar 

  13. Raptis AE, Viberti G (2001) Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes 109(Suppl 2):S424–S437

    Article  CAS  Google Scholar 

  14. Chen S, Jim B, Ziyadeh FN (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23:532–543

    Article  CAS  Google Scholar 

  15. Hellmich B, Schellner M, Schatz H, Pfeiffer A (2000) Activation of transforming growth factor-beta1 in diabetic kidney disease. Metabolism 49:353–359

    Article  CAS  Google Scholar 

  16. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S (1993) Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Investig 68:154–163

    CAS  PubMed  Google Scholar 

  17. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, Border WA (1996) Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int 49:461–469

    Article  CAS  Google Scholar 

  18. Hathaway CK, Gasim AM, Grant R, Chang AS, Kim HS, Madden VJ, Bagnell CR Jr, Jennette JC, Smithies O, Kakoki M (2015) Low TGFbeta1 expression prevents and high expression exacerbates diabetic nephropathy in mice. Proc Natl Acad Sci U S A 112:5815–5820

    Article  CAS  Google Scholar 

  19. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, Chen S (2009) The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 297:F85–F94

    Article  CAS  Google Scholar 

  20. Sato H, Iwano M, Akai Y, Kurioka H, Kubo A, Yamaguchi T, Hirata E, Kanauchi M, Dohi K (1998) Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy. Am J Nephrol 18:490–494

    Article  CAS  Google Scholar 

  21. Korpinen E, Teppo AM, Hukkanen L, Akerblom HK, Gronhagen-Riska C, Vaarala O (2000) Urinary transforming growth factor-beta1 and alpha1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care 23:664–668

    Article  CAS  Google Scholar 

  22. Flores L, Naf S, Hernaez R, Conget I, Gomis R, Esmatjes E (2004) Transforming growth factor beta at clinical onset of type 1 diabetes mellitus. A pilot study. Diabet Med 21:818–822

    Article  CAS  Google Scholar 

  23. Zorena K, Raczynska D, Wisniewski P, Malinowska E, Mysliwiec M, Raczynska K, Rachon D (2013) Relationship between serum transforming growth factor beta 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents. Mediat Inflamm 2013:849457

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Happy Sawires.

Ethics declarations

The study was conducted in accordance with the Declaration of Helsinki and approved by the local ethics committee.

Conflict of interest

The authors declare that they have no conflict of interest.

Human and animal rights and informed consent

An informed consent was obtained from patients’ caregivers. The research does not include animals and there were no clinical trials on human subjects.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sawires, H., Botrous, O., Aboulmagd, A. et al. Transforming growth factor-β1 in children with diabetic nephropathy. Pediatr Nephrol 34, 81–85 (2019). https://doi.org/10.1007/s00467-018-4062-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-018-4062-8

Keywords

Navigation